Literature DB >> 323381

Protective effects of passively transferred immune T- or B-lymphocytes in mice infected with Salmonella typhimurium.

J F Hochadel, K F Keller.   

Abstract

Purified populations of bone marrow-derived (B-) lymphocytes and thymus-derived (T-) lymphocytes were obtained from C3D2F1 hybrid mice shown to be immune to Salmonella typhimurium. These subpopulations of lymphocytes were injected into normal mice; four days later the animals were challenged with 50 50% lethal doses of S. typhimurium, and viable bacteria in livers, spleens, and blood were counted at various intervals after challenge. On day 8 after challenge, the mice supplemented with B-lymphocytes showed a significant decrease in the number of organisms recovered from all three sites, compared with that seen in recipients of T-lymphocytes and in controls. The mice given B-lymphocytes showed a better rate of survival (65%) than mice that received only T-lymphocytes (21%) or T-lymphocyte fractions contaminated 10%-30% with B-lymphocytes (49%). These data indicate that, although the humoral response is not totally protective, it does play an important role in the suppression of the infection during its early stages.

Entities:  

Mesh:

Year:  1977        PMID: 323381     DOI: 10.1093/infdis/135.5.813

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  T cells do not mediate the initial suppression of a Salmonella infection in the RES.

Authors:  C E Hormaeche; P Mastroeni; A Arena; J Uddin; H S Joysey
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

2.  Analysis of immunity to infection with Salmonella typhimurium in outbred mice. II. Isolation and immunogenicity of the protective non-O antigenic component from ribosomal vaccine.

Authors:  E Kita; M Emoto; N Katsui; K Nishi; K Yasui; K Yasui; S Kashiba
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

3.  Phagocytosis and killing of salmonella typhimurium by peritoneal exudate cells.

Authors:  D E Briles; J Lehmeyer; C Forman
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

4.  In vivo analysis of impaired macrophage bactericidal capacity during experimental African trypanosomiasis.

Authors:  D L Glick; J F Jones
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

5.  Predominant activation and expansion of V gamma 9-bearing gamma delta T cells in vivo as well as in vitro in Salmonella infection.

Authors:  T Hara; Y Mizuno; K Takaki; H Takada; H Akeda; T Aoki; M Nagata; K Ueda; G Matsuzaki; Y Yoshikai
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

6.  O antigen as virulence factor in mouse typhoid: effect of B-cell suppression.

Authors:  M V Valtonen; P Häyry
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

7.  Adoptive transfer of immunity to oral challenge with virulent salmonellae in innately susceptible BALB/c mice requires both immune serum and T cells.

Authors:  P Mastroeni; B Villarreal-Ramos; C E Hormaeche
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  Stimulation of cell-mediated immunity by bestatin correlates with reduction of bacterial persistence in experimental chronic Salmonella typhimurium infection.

Authors:  G Dickneite; F Kaspereit; H H Sedlacek
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

9.  Characterization and development of T-Cell immune responses in B-cell-deficient (Igh-6(-/-)) mice with Salmonella enterica serovar Typhimurium infection.

Authors:  Sanja Ugrinovic; Nathalie Ménager; Natalie Goh; Pietro Mastroeni
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

10.  Vaccination of mice with salmonella expressing VapA: mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection.

Authors:  Aline F Oliveira; Luciana P Ruas; Silvia A Cardoso; Sandro G Soares; Maria-Cristina Roque-Barreira
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.